DSIP dosage chart
This summary table compares available dose amounts and schedules by administration route.
| Route | Dose | Frequency & duration |
|---|---|---|
| Injectable | 100–300 mcg | Nightly · 2–6 wk |
| Intranasal | 300 mcg (Deltaran) | Once daily · 5 days |
| Transdermal | 3.5 mL of 0.2 mg/mL donor solution (0.7 mg loaded) | Single laboratory exposure · 9-hour sampling period |
DSIP dosage by administration route
DSIP injectable dosage
Reported-use amounts for DSIP are 100–300 mcg per administration, nightly, for 2–6 wk. Another reported subcutaneous amount is 200–400 mcg daily in 5–10-day courses. This is a separate shorter pattern from the 2–6-week injectable course above and is not interchangeable with the Deltaran nasal formulation.[12][13]
DSIP is a nine-amino-acid peptide associated with sleep and stress-response signaling. Proposed sleep effects do not establish a dependable insomnia treatment.[1][2][3][12]
DSIP intranasal — deltaran formulation dosage
The documented Deltaran nasal formulation uses 300 mcg once daily for five days. Its concentration and directions define a separate preparation from injectable DSIP.[11]
DSIP is a nine-amino-acid peptide associated with sleep and stress-response signaling. Proposed sleep effects do not establish a dependable insomnia treatment.[5][11][1][2][3]
DSIP transdermal — ex vivo iontophoresis dosage
The iontophoresis experiment loads 3.5 mL of 0.2 mg/mL DSIP solution into the donor chamber, totaling 0.7 mg over 0.785 cm² of excised rabbit-ear skin. Samples are collected over 9 hours while pH, current and enzyme inhibitors are compared. This is a laboratory reservoir amount, not a sleep-treatment patch dose.[6]
The experiment uses cathodal iontophoresis rather than a passive adhesive patch. Its donor concentration, enzyme-inhibitor conditions and measured skin flux describe a laboratory delivery system.[6][1][2][3]
DSIP dosage calculator
Convert your chosen DSIP amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.
DSIP safety and side effects
Common DSIP dosage questions
Can DSIP doses be transferred between routes?
What dosage is listed for DSIP?
Sources
Show citationsHide citations
- [1]Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.Neuropsychobiology, 1992. human clinical.
- [2]Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.Eur Neurol, 1987. human clinical.
- [3]Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study.Eur Neurol, 1984. human clinical.
- [4]Search Drugs@FDA for DSIPU.S. Food and Drug Administration. database query.
- [5]Intranasal administration of delta sleep-inducing peptide increases P300.J Clin Psychopharmacol, 2001 Dec. human clinical.
- [6]Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide.Drug development and industrial pharmacy, 1998 May. ex vivo.
- [7]Delta sleep-inducing peptide.Eur J Anaesthesiol, 2001 Jul. review.
- [8]Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration. official guidance.
- [9]Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C ActU.S. Food and Drug Administration, 2026-05-14. official guidance.
- [10]Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C ActU.S. Food and Drug Administration, 2025-01-07. regulatory.
- [11]Deltaran official registered instructionsMEDI.RU / Russian Ministry of Health instruction archive, 2017-03-25. reference catalog.
- [12]PepFlow peptide cheat sheet — reported-use and product-orientation reference (not clinical research)PepFlow. reference catalog.
- [13]DSIP — Everything Peptide reported protocol (educational reference, not clinical evidence)Everything Peptide. reference catalog.


